SQZB Stock Chart & Stats
$0.02
$0.00(0.00%)
At close: 4:00 PM EST
$0.02
$0.00(0.00%)
Day’s Range― - ―
52-Week Range$0.02 - $0.05
Previous CloseN/A
Volume166.00
Average Volume (3M)7.07K
Market Cap
$707.79K
Enterprise Value$13.65
Total Cash (Recent Filing)$10.19M
Total Debt (Recent Filing)$21.47M
Price to Earnings (P/E)―
Beta1.01
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding29,491,125
10 Day Avg. Volume452
30 Day Avg. Volume7,069
Financial Highlights & Ratios
PEG Ratio-0.02
Price to Book (P/B)0.37
Price to Sales (P/S)1.01
P/FCF Ratio-0.25
Enterprise Value/Market Cap<0.01
Enterprise Value/Revenue<0.01
Enterprise Value/Gross Profit<0.01
Enterprise Value/Ebitda>-0.01
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
SQZB FAQ
What was SQZ Biotechnologies’s price range in the past 12 months?
SQZ Biotechnologies lowest stock price was $0.02 and its highest was $0.05 in the past 12 months.
What is SQZ Biotechnologies’s market cap?
SQZ Biotechnologies’s market cap is $707.79K.
When is SQZ Biotechnologies’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were SQZ Biotechnologies’s earnings last quarter?
Currently, no data Available
Is SQZ Biotechnologies overvalued?
According to Wall Street analysts SQZ Biotechnologies’s price is currently Overvalued.
Does SQZ Biotechnologies pay dividends?
SQZ Biotechnologies does not currently pay dividends.
What is SQZ Biotechnologies’s EPS estimate?
SQZ Biotechnologies’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does SQZ Biotechnologies have?
SQZ Biotechnologies has 29,491,125 shares outstanding.
What happened to SQZ Biotechnologies’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of SQZ Biotechnologies?
Currently, no hedge funds are holding shares in SQZB
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
SQZ Biotechnologies
SQZ Biotechnologies Company, a clinical-stage biotechnology company, develops cell therapies for patients with cancer, infectious diseases, and other serious conditions in Massachusetts. Its lead product candidate is SQZ-PBMC-HPV, from its SQZ Antigen Presenting Cells platform, which is in a Phase I clinical trial as a monotherapy and in combination with immuno-oncology agents for the treatment of HPV16+ advanced or metastatic solid tumors, including cervical, head-and-neck, anal, penile, vulvar, and vaginal cancer. The company also develops SQZ-AAC-HPV and SQZ-eAPC-HPV, which is in a Phase I clinical trial for the treatment of HPV16+ advanced or metastatic solid tumors in monotherapy and in combinations with immune-oncology agents. Its additional platforms in development are SQZ Activating Antigen Carriers; and SQZ Tolerizing Antigen Carriers. The Company was incorporated in 2013 and is headquartered in Watertown, Massachusetts.
Technical Analysis
Ownership Overview
―
Insiders
―
Mutual Funds
5.49% Other Institutional Investors
94.51% Public Companies and
Individual Investors